Oura Acquires Veri to Enhance Metabolic Health Tracking

The acquisition aims to integrate continuous glucose monitoring and personalized health insights into Oura's platform.

Oura has acquired Helsinki-based metabolic health startup Veri, which uses continuous glucose monitors (CGMs) to track meals and glucose levels.
This acquisition marks Oura's second major purchase, following its acquisition of digital identification tech company Proxy in May 2023.
97% of Oura users are interested in understanding how nutrition affects their health, with 13% having already used CGMs.
Veri's platform will be integrated into Oura's health suite by the end of 2024, with a transition plan in place for existing Veri users.
The FDA's recent clearance of over-the-counter CGMs is expected to increase accessibility and awareness of glucose and metabolic health.